| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | Canada | 4 | |
| #3 | New Zealand | 2 | |
| #4 | Serbia | 2 | |
| #5 | China | 1 | |
| #6 | Colombia | 1 | |
| #7 | Ecuador | 1 | |
| #8 | Mexico | 1 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Duffield Andrew John | 13 |
| #2 | Green Brendan Mark | 2 |
| #3 | Nichols Philip Paul | 2 |
| #4 | Oakes Roger Anthony | 2 |
| #5 | Duffield Andrew | 2 |
| #6 | Williams Neil Andrew | 2 |
| #7 | Johnston Grant | 2 |
| #8 | Yarrow Jean Elisabeth | 2 |
| #9 | Townsley John Christopher | 2 |
| #10 | Grayson Ben | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2739209A1 | Use of 3,11b-cis-dihydrobenazine in the treatment of dementia and associated cognitive deficit | |
| CA2739201A1 | Pharmaceutical compounds | |
| CA2739199A1 | Dihydrotetrabenazine for treatment of asthma | |
| WO2010018408A2 | Pharmaceutical compositions with tetrabenazine | |
| NZ566011A | 3, 11b cis dihydrotetrabenazine for the treatment of schizophrenia and other psychoses |